ImmuPharma plc (AIM:IMM)
4.200
-0.378 (-8.25%)
Apr 28, 2026, 4:35 PM GMT
ImmuPharma Employees
ImmuPharma had 6 employees as of December 31, 2024. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-655.75K GBP
Market Cap
26.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sareum Holdings | 5 |
| SkinBioTherapeutics | 41 |
| Poolbeg Pharma | 16 |
| Arecor Therapeutics | 44 |
| Aptamer Group | 30 |
| Fusion Antibodies | 24 |
| IXICO | 79 |
| Hemogenyx Pharmaceuticals | 16 |
ImmuPharma News
- 5 weeks ago - ImmuPharma Transcript: Investor update - Transcripts
- 6 weeks ago - AIM Market Roundup: Tern, T42 IoT, Atlantic Lithium - The Armchair Trader
- 2 months ago - AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West - The Armchair Trader
- 5 months ago - FTSE Flat as Wall Street Gains Fail to Inspire - Investomania
- 5 months ago - AIM Market Roundup: Trellus Health, Great Western Mining, EMV Capital - The Armchair Trader
- 8 months ago - AIM Market Roundup: ImmuPharma, Rockfire Resources, Likewise - The Armchair Trader
- 8 months ago - AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals - The Armchair Trader
- 8 months ago - AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien - The Armchair Trader